Scilex Holding Company (SCLXW)

USD 0.21

(-23.88%)

Net Income Summary of Scilex Holding Company

  • Scilex Holding Company's latest annual net income in 2023 was -114.33 Million USD , down -389.35% from previous year.
  • Scilex Holding Company's latest quarterly net income in 2024 Q2 was -37.58 Million USD , down -54.17% from previous quarter.
  • Scilex Holding Company reported an annual net income of -23.36 Million USD in 2022, up 73.58% from previous year.
  • Scilex Holding Company reported an annual net income of -88.42 Million USD in 2021, down -86.08% from previous year.
  • Scilex Holding Company reported a quarterly net income of -37.58 Million USD for 2024 Q2, down -54.17% from previous quarter.
  • Scilex Holding Company reported a quarterly net income of -30.75 Million USD for 2023 Q1, down -71.96% from previous quarter.

Annual Net Income Chart of Scilex Holding Company (2023 - 2019)

Historical Annual Net Income of Scilex Holding Company (2023 - 2019)

Year Net Income Net Income Growth
2023 -114.33 Million USD -389.35%
2022 -23.36 Million USD 73.58%
2021 -88.42 Million USD -86.08%
2020 -47.51 Million USD 73.39%
2019 -178.59 Million USD 0.0%

Peer Net Income Comparison of Scilex Holding Company

Name Net Income Net Income Difference
Amgen Inc. 6.71 Billion USD 101.702%
AstraZeneca PLC 5.95 Billion USD 101.92%
Biogen Inc. 1.16 Billion USD 109.847%
Gilead Sciences, Inc. 5.66 Billion USD 102.018%
MIRA Pharmaceuticals, Inc. -11.98 Million USD -854.162%
Scilex Holding Company -114.33 Million USD -0.0%